化学发光法幽门螺杆菌粪便抗原检测的多中心诊断性能与干扰分析
本研究在中国四家三级医院前瞻性纳入741名受试者,以尿素呼气试验为参考标准,评估MAGLUMI幽门螺杆菌抗原化学发光免疫分析法的诊断性能。该方法批内变异系数小于5%,灵敏度94.59%、特异性97.76%,与尿素呼气试验一致性极好(Kappa=0.9258);按尿素呼气试验值分层分析显示不同感染负荷下诊断性能存在差异。该方法在不同粪便性状及粪便常规异常样本中性能一致,总体准确率超过91.30%。
要点
- MAGLUMI幽门螺杆菌粪便抗原CLIA灵敏度94.59%、特异性97.76%,与UBT一致性Kappa=0.9258。
- 按UBT值分层分析显示不同感染负荷下诊断性能存在差异。
- 不同粪便性状及粪便常规异常样本中总体准确率超过91.30%。
核心结论
- MAGLUMI幽门螺杆菌抗原CLIA是一种可靠的非侵入性诊断方法,具有良好临床适用性和泛化性。
- 该方法在不同临床场景中表现稳定,支持其作为诊断幽门螺杆菌感染的有效工具。
研究设计与样本
- 前瞻性多中心研究,在中国四家三级医院纳入741名受试者。
- 以尿素呼气试验为参考标准评估MAGLUMI幽门螺杆菌抗原CLIA的诊断性能。
- 基于连续尿素呼气试验值进行分层分析以探索影响因素。
主要发现
- 该方法精密度高,变异系数小于5%。
- 诊断灵敏度94.59%,特异性97.76%,与尿素呼气试验一致性极好(Kappa=0.9258)。
- 分层分析显示不同感染负荷水平下诊断性能存在差异。
- 不同粪便性状及粪便常规异常临床样本中性能一致,总体准确率超过91.30%,且在这些有限样本中CLIA与UBT完全一致。
关键数值与推荐
- 灵敏度94.59%,特异性97.76%,Kappa=0.9258,变异系数小于5%。
- 总体准确率超过91.30%(粪便性状及粪便常规异常样本)。
临床怎么用
- 可作为幽门螺杆菌感染的非侵入性诊断工具,适用于不同粪便性状样本。
- 解读结果时应考虑感染负荷对诊断性能的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Helicobacter pylori (H. pylori) infection remains a significant global health challenge, and accurate non-invasive diagnostic methods are essential for effective clinical management. This study aimed to evaluate the diagnostic performance of the MAGLUMI H. pylori antigen chemiluminescent immunoassay (CLIA) in a multicenter setting and compare its efficacy with the urea breath test (UBT), which served as the reference standard. METHODS: A prospective multicenter study was conducted across four tertiary hospitals in China, enrolling 741 subjects. The diagnostic performance of the MAGLUMI H. pylori antigen CLIA was assessed using UBT as the reference standard, and influencing factors were explored through stratified analysis based on continuous UBT values. RESULTS: The assay demonstrated high precision with a coefficient of variation (CV) of less than 5%. The diagnostic sensitivity was 94.59%, and specificity was 97.76%, with excellent agreement with UBT (Kappa = 0.9258). Stratified analysis revealed variations in diagnostic performance across different infection burden levels. Furthermore, the assay showed consistent performance across different stool consistencies and in clinical samples with abnormal stool findings, achieving an overall accuracy exceeding 91.30%, and complete agreement between CLIA and UBT was observed in these limited samples. CONCLUSION: The MAGLUMI H. pylori antigen CLIA is a reliable, non-invasive diagnostic method with excellent clinical applicability and generalizability. Its strong performance across diverse clinical scenarios supports its potential as an effective tool for diagnosing H. pylori infection.
引用
- Wang Z, Chen X, Lu H, et al. Diagnostic performance and interference analysis of a chemiluminescent H. pylori stool antigen assay stratified by 13C-urea breath test values in a multicenter study. Clin Chim Acta. 2026. PMID: 42486318. doi:10.1016/j.cca.2026.121236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。